trial

PS-Trauma - Development of Trauma Treatment for Patients With Co-morbid Psychotic Disorders and Traumas

NCTId NCT07242586
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 20 (estimated)
Sponsored by Nikolai Albert
Primary completion 2026-05-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
20 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2025-10-02
Primary completion
2026-05-31
Eligibility
ALL · 18 Years · 35 Years

Interventions & indications

Drugs
Prolonged ExposureEMDR

Sponsors

Nikolai AlbertLead Sponsor

Investigators

1
Nikolai AlbertPrincipal Investigator

Sites

1 total
Copenhagen, Denmark

Facts & assertions

4 sourced
Enrollment
20
Phase
NA
Primary Completion Date
2026-05-31
Status
RECRUITING
relationships
The graph out of here
drug
Prolonged Exposure
drug
EMDR
drug
lead_sponsor
Nikolai Albert
company
indication
Schizotypal Disorder
indication
Schizotypal Personality Disorder
indication
Schizophrenia
indication
investigator
Nikolai Albert
person